Meta Pixel

Grabba Technologies Pty Ltd

Australia|Electronic Equipment & Instruments

Overview

Grabba Technologies Pty Ltd

'Grabba' is an advanced manufacturer of proprietary biometric devices (identity authentication products) and complex electronics. Since being acquired by its current owners in 2017, Grabba has strengthened its market position in two key markets: 

  • North America: US Federal market with a focus on Customs and Border Protection (Department of Homeland Security); policing; and public safety.
  • Gulf States: Grabba is one of a select few biometric hardware manufacturers that supplies into the GCC market for commercial transactions. There are seven Gulf States that have developed national biometric databases and require personal identity checks for a growing range of commercial transactions, e.g., purchasing a SIM card, receiving courier deliveries, and banking (Know Your Customer (KYC) and Anti Money Laundering (AML)).

Grabba’s handheld devices are used to capture an individual’s biometric data, such as fingerprints, face and iris. To date over 20,000 devices have been sold globally.

The business has two divisions Grabba Technologies Pty Ltd (Grabba) and CrystalAid Manufacture Pty Ltd (CrystalAid). Both companies operate from a single modern manufacturing facility in Brisbane, Australia. All manufacturing phases (R&D, design, logistics, production, distribution, sales, and marketing) are controlled by the group with low supply chain risks. The micro-electronics and software (SDK) are developed and produced in house, which provides a level of security and resilience. Advanced production processes allow for rapid customisation of products to satisfy client specific needs. Enabling product customisation without margin erosion is a key differentiator in the market. 

As an Australian manufacturer of biometric products, Grabba is perceived favourably by its growing cadre of high-profile repeat customers. Trusted relationships with the biometric data owners and national authorities are the true value of the company and creates a high barrier to entry for competitors. The level of trust that Grabba has established with customers and authorities is highly valuable and difficult to replicate. These relationships also provide a growth opportunity into the wider global market.

CrystalAid manufactures complex electronics (PCBs). Purchased in 2019, the facility was originally the manufacturing arm of Cochlear implants and now manufactures the core microelectronics for the Grabba product. As one the few AS9100D certified companies with core capabilities in electronics manufacturing, it also produces non-proprietary products for the defence, aerospace, medical, mining, and other commercial sectors.

 

 

Problem and Solution

Ut dignissim eget felis non ultrices. Vivamus fermentum erat at velit varius molestie.

Duis vitae mi neque.



Donec tincidunt, dolor luctus lobortis ultrices, turpis eros cursus turpis, maximus tempor lectus lectus vel diam.



Proin neque lacus, semper vel ex at, eleifend rhoncus est.

Cras non nisi urna. Sed feugiat dignissim erat, eget convallis nisl blandit a. Nullam fringilla diam eget dui placerat fermentum. Maecenas malesuada viverra leo eu bibendum. Nam vulputate enim velit, eu pretium justo tristique ac.



Nam vitae varius augue. Nam pharetra facilisis elementum. Sed nisl risus, vestibulum ut velit at, dapibus sagittis arcu. Nullam sed dolor suscipit, efficitur enim quis, vestibulum sapien. Nunc convallis mauris nec nibh mollis, eget aliquet odio tincidunt.

Phasellus faucibus sem mauris, sed iaculis nisl egestas sed. Sed sit amet gravida elit, sagittis sollicitudin nulla. Vivamus auctor arcu eu scelerisque convallis. Phasellus scelerisque ultrices tincidunt. Curabitur odio libero, faucibus et felis nec, pulvinar facilisis urna. Interdum et malesuada fames ac ante ipsum primis in faucibus. Maecenas ultrices in velit at ultrices.



Pellentesque tempor a risus in elementum. Proin malesuada mauris et mauris bibendum laoreet. Vivamus maximus nulla volutpat, ornare lorem a, vulputate enim.

In dui nisl, vestibulum eu finibus pretium, eleifend et eros. Vivamus in venenatis risus, ut dictum vel

Market Opportunity

Ut dignissim eget felis non ultrices. Vivamus fermentum erat at velit varius molestie.

Duis vitae mi neque.



Donec tincidunt, dolor luctus lobortis ultrices, turpis eros cursus turpis, maximus tempor lectus lectus vel diam.



Proin neque lacus, semper vel ex at, eleifend rhoncus est.

Cras non nisi urna. Sed feugiat dignissim erat, eget convallis nisl blandit a. Nullam fringilla diam eget dui placerat fermentum. Maecenas malesuada viverra leo eu bibendu

Competitive Advantage

Pellentesque tempor a risus in elementum. Proin malesuada mauris et mauris bibendum laoreet.



Vivamus maximus nulla volutpat, ornare lorem a, vulputate enim. In dui nisl, vestibulum eu finibus pretium, eleifend et eros. Vivamus in venenatis risus, ut dictum velit. Praesent rhoncus tempor fermentum. In malesuada tellus eu volutpat posuere. Nullam ut dignissim libero, ut pharetra leo. Nullam sit amet aliquam felis. Suspendisse volutpat ante eget tincidunt feugiat. Nunc placerat sapien et metus molestie, in viverra augue viverra. Donec varius metus ut arcu vestibulum hendrerit. Sed viverra risus neque, ac commodo enim lacinia at.



Morbi posuere tortor vitae sapien faucibus auctor. Donec nulla ipsum, aliquet non bibendum sit amet, viverra non metus. Sed blandit effic

Highlights & Milestones

Ut dignissim eget felis non ultrices. Vivamus fermentum erat at velit varius molestie.



Duis vitae mi neque. Donec tincidunt, dolor luctus lobortis ultrices, turpis eros cursus turpis, maximus tempor lectus lectus vel diam.

Proin neque lacus, semper vel ex at, eleifend rhoncus est.

Cras non nisi urna. Sed feugiat dignissim erat, ege

See more exiting opportunities on CapitalHQ

Pictor

Powering diagnostics with protein signatures. Pictor is transforming health with its patented platform providing accessible, affordable, and scalable diagnostic solutions across the human and animal health verticals. PictArray can detect up to 10 diseases or biomarkers from one small serum, milk,...

flag_new zealand
New Zealand NZD
Biotechnology Series B+

ProxyTwin

ProxyTwin™ amplifies expertise. ProxyTwin is a digital twin that works for experts so they can help more people. We create advanced digital replicas of real individuals, enabling them to virtually attend meetings, deliver messages, and hold thousands of interactions simultaneously. Recently...

flag_australia
Australia AUD
Artificial Intelligence Seed Round

HorizonTwo Capital Partners

HorizonTwo Capital Partners is a private equity firm that specialises in advanced manufacturing companies.

flag_australia
Australia AUD
Advanced Manufacturing Private Placement

The Insides Company

First-in-class medtech for intestinal failure. Seeking remaining $1M of a $5M round, on a AUD$17.2M pre-money valuation.

flag_new zealand
New Zealand AUD
Medical Devices Series A

DCARB

We are aiming to raise $CAD5M to fund the ongoing commercialisation of the D100 unit, including working capital to fund the expected growth in sales, and a field trial of the DArc unit. This follows a successful Series B round completed in mid-2023.

flag_australia
Australia CAD
Green Hydrogen Series B+

Grabba Technologies Pty Ltd

Advanced manufacturer of biometric identity authorisation products and electronics supplier to defence industry. We invite expressions of interest for up to $10.0M in growth capital.

flag_australia
Australia AUD
Electronic Equipment & Instruments Private Placement

Join over 45,000+ sophisticated investors

Join Now